Abstract
Backbone structure of heparan sulfate (HS) and heparin is composed of HexA-GlcNAc/GlcNSO3 repeating units, in which HexA is either d-GlcA or l-IdoA, linked to core proteins through a tetrasaccharide linkage sequence, GlcA-Gal-Gal-Xyl. Sulfate groups are present on the position 2 of the HexA, position 3 and 6 of the GlcNAc/GlcNSO3, and position 2 in the GlcNSO3. Heparan sulfate 2-O-sulfotransferase (HS2ST) transfers sulfate from 3′-phosphoadenosine 5′-phosphosulfate (PAPS) to position 2 of the IdoA and GlcA residue in HS and heparin.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K (2004) Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 279:12346–12354
Ashikari-Hada S, Habuchi H, Kariya Y, Kimata K (2005) Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins. J Biol Chem 280:31508–31515
Ashikari-Hada S, Habuchi H, Sugaya N, Kobayashi T, Kimata K (2009) Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate. Glycobiology 19:644–654
Axelsson J, Xu D, Kang BN, Nussbacher JK, Handel TM, Ley K, Sriramarao P, Esko JD (2012) Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice. Blood 120:1742–1751
Bai X, Esko JD (1996) An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J Biol Chem 271:17711–17717
Bai X, Bame KJ, Habuchi H, Kimata K, Esko JD (1997) Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids. J Biol Chem 272:23172–23179
Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729–777
Bethea HN, Xu D, Liu J, Pedersen LC (2008) Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis. Proc Natl Acad Sci USA 105:18724–18729
Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030–1037
Bullock SL, Fletcher JM, Beddington RS, Wilson VA (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev 12:1894–1906
Bülow HE, Hobert O (2004) Differential sulfations and epimerization define heparan sulfate specificity in nervous system development. Neuron 41:723–736
Bülow HE, Hobert O (2006) The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol 22:375–407
Conway CD, Howe KM, Nettleton NK, Price DJ, Mason JO, Pratt T (2011) Heparan sulfate sugar modifications mediate the functions of slits and other factors needed for mouse forebrain commissure development. J Neurosci 31:1955–1970
DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, Hendrickson WA (1998) Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 393:812–817
Fadel S, Eley A (2008) Differential glycosaminoglycan binding of Chlamydia trachomatis OmcB protein from serovars E and LGV. J Med Microbiol 57(Pt 9):1058–1061
Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116–1120
Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 268:23906–23914
Habuchi H, Suzuki S, Saito T, Tamura T, Harada T, Yoshida K, Kimata K (1992) Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochem J 285:805–813
Habuchi H, Habuchi O, Kimata K (1995) Purification and characterization of heparan sulfate 6-sulfotransferase from the culture medium of Chinese hamster ovary cells. J Biol Chem 270:4172–4179
Habuchi H, Kobayashi M, Kimata K (1998) Molecular characterization and expression of heparan-sulfate 6-sulfotransferase. Complete cDNA cloning in human and partial cloning in Chinese hamster ovary cells. J Biol Chem 273:9208–9213
Habuchi H, Tanaka M, Habuchi O, Yoshida K, Suzuki H, Ban K, Kimata K (2000) The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J Biol Chem 275:2859–2868
Habuchi H, Habuchi O, Uchimura K, Kimata K, Muramatsu T (2006) Determination of substrate specificity of sulfotransferases and glycosyltransferases (proteoglycans). Methods Enzymol 416:225–243
Irie F, Badie-Mahdavi H, Yamaguchi Y (2012) Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. Proc Natl Acad Sci USA 109:5052–5056
Ishihara M, Takano R, Kanda T, Hayashi K, Hara S, Kikuchi H, Yoshida K (1995) Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2. J Biochem 118:1255–1260
Jastrebova N, Vanwildemeersch M, Rapraeger AC, Giménez-Gallego G, Lindahl U, Spillmann D (2006) Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors. J Biol Chem 281:26884–26892
Jones KS, Lambert S, Bouttier M, Bénit L, Ruscetti FW, Hermine O, Pique C (2011) Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors. Viruses 3:794–810
Kakuta Y, Pedersen LG, Carter CW, Negishi M, Pedersen LC (1997) Crystal structure of estrogen sulphotransferase. Nat Struct Biol 4:904–908
Kamimura K, Koyama T, Habuchi H, Ueda R, Masu M, Kimata K, Nakato H (2006) Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling. J Cell Biol 174:773–778
Kan M, Wang F, Xu J, Crabb JW, Hou J, McKeehan WL (1993) An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259:1918–1921
Kimata K, Habuchi O, Habuchi H, Watanabe H (2007) Knockout mice and proteoglycans in comprihensive glycoscience, vol 3. Elsevier, pp 119–159, Chapter 4.10
Kinnunen T, Huang Z, Townsend J, Gatdula MM, Brown JR, Esko JD, Turnbull JE (2005) Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans. Proc Natl Acad Sci USA 102:1507–1512
Kobayashi M, Habuchi H, Habuchi O, Saito M, Kimata K (1996) Purification and characterization of heparan sulfate 2-sulfotransferase from cultured Chinese hamster ovary cells. J Biol Chem 271:7645–7653
Kobayashi M, Habuchi H, Yoneda M, Habuchi O, Kimata K (1997) Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase. J Biol Chem 272:13980–13985
Kobayashi T, Habuchi H, Tamura K, Ide H, Kimata K (2007) Essential role of heparan sulfate 2-O-sulfotransferase in chick limb bud patterning and development. J Biol Chem 282:19589–19597
Kolset SO, Pejler G (2011) Serglycin: a structural and functional chameleon with wide impact on immune cells. J Immunol 187:4927–4933
Lindahl B, Eriksson L, Lindahl U (1995) Structure of heparan sulphate from human brain, with special regard to Alzheimer’s disease. Biochem J 306:177–184
MacArthur JM, Bishop JR, Stanford KI, Wang L, Bensadoun A, Witztum JL, Esko JD (2007) Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117:153–164
Maccarana M, Casu B, Lindahl U (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 268:23898–23905
McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, Dyer AP, Tufaro F (1998) The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet 19:158–161
Melo FR, Grujic M, Spirkoski J, Calounova G, Pejler G (2012) Serglycin proteoglycan promotes apoptotic versus necrotic cell death in mast cells. J Biol Chem 287:18142–18152
Merry CL, Bullock SL, Swan DC, Backen AC, Lyon M, Beddington RS, Wilson VA, Gallagher JT (2001) The molecular phenotype of heparan sulfate in the Hs2st−/− mutant mouse. J Biol Chem 276:35429–35434
Merry CL, Wilson VA (2002) Role of heparan sulfate-2-O-sulfotransferase in the mouse. Biochim Biophys Acta 1573:319–327
Moon AF, Edavettal SC, Krahn JM, Munoz EM, Negishi M, Linhardt RJ, Liu J, Pedersen LC (2004) Structural analysis of the sulfotransferase (3-O-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1. J Biol Chem 279:45185–45193
Nogami K, Suzuki H, Habuchi H, Ishiguro N, Iwata H, Kimata K (2004) Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds. J Biol Chem 279:8219–8229
Perrimon N, Bernfield M (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404:725–728
Plotnikov AN, Schlessinger J, Hubbard SR, Mohammadi M (1999) Structural basis for FGF receptor dimerization and activation. Cell 98:641–650
Pratt T, Conway CD, Tian NM, Price DJ, Mason JO (2006) Heparan sulphation patterns generated by specific heparan sulfotransferase enzymes direct distinct aspects of retinal axon guidance at the optic chiasm. J Neurosci 26:6911–6923
Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT (1998) Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 273:22936–22942
Qu X, Carbe C, Tao C, Powers A, Lawrence R, van Kuppevelt TH, Cardoso WV, Grobe K, Esko JD, Zhang X (2011) Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate. J Biol Chem 286:14435–14444
Qu X, Pan Y, Carbe C, Powers A, Grobe K, Zhang X (2012) Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development. Development 139:2730–2739
Rapraeger AC, Krufka A, Olwin BB (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705–1708
Rong J, Habuchi H, Kimata K, Lindahl U, Kusche-Gullberg M (2001) Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. Biochemistry 40:5548–5555
Scholefield Z, Yates EA, Wayne G, Amour A, McDowell W, Turnbull JE (2003) Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer’s beta-secretase. J Cell Biol 163:97–107
Selleck SB (2000) Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics. Trends Genet 16:206–212
Shively JE, Conrad HE (1976) Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15:3932–3942
Smeds E, Feta A, Kusche-Gullberg M (2010) Target selection of heparan sulfate hexuronic acid 2-O-sulfotransferase. Glycobiology 20:1274–1282
Stanford KI, Wang L, Castagnola J, Song D, Bishop JR, Brown JR, Lawrence R, Bai X, Habuchi H, Tanaka M, Cardoso WV, Kimata K, Esko JD (2010) Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem 285:286–294
Stevens RL, Adachi R (2007) Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity. Immunol Rev 217:155–167
Turnbull JE, Fernig DG, Ke Y, Wilkinson MC, Gallagher JT (1992) Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem 267:10337–10341
Wang L, Fuster M, Sriramarao P, Esko JD (2005) Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 6:902–910
Wlad H, Maccarana M, Eriksson I, Kjellén L, Lindahl U (1994) Biosynthesis of heparin. Different molecular forms of O-sulfotransferases. J Biol Chem 269:24538–24541
Yabushita H, Noguchi Y, Habuchi H, Ashikari S, Nakabe K, Fujita M, Noguchi M, Esko JD, Kimata K (2002) Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture. Glycobiology 12:345–351
Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841–848
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this entry
Cite this entry
Habuchi, H. (2014). Heparan Sulfate 2-O-Sulfotransferase (HS2ST). In: Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T. (eds) Handbook of Glycosyltransferases and Related Genes. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54240-7_67
Download citation
DOI: https://doi.org/10.1007/978-4-431-54240-7_67
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54239-1
Online ISBN: 978-4-431-54240-7
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences